-

Frazier Healthcare Partners Adds Highly Experienced Pharma Executive to Growth Buyout Team

SEATTLE--(BUSINESS WIRE)--Frazier Healthcare Partners, a private equity firm focused exclusively on the healthcare industry, is pleased to announce that Willis Chandler has joined the firm’s Growth Buyout team as an Executive in Residence. Mr. Chandler will work alongside the firm to develop and execute investment strategies focused on pharma and pharmacy services. In this role, he will focus on the sourcing, diligence, and leadership of a new platform investment for Frazier.

“The secular growth in pharma and pharmacy services has been an area of focus for Frazier for several years, and we are thrilled to welcome an industry veteran like Willis to our team,” said Nathan Every, General Partner at Frazier. “We are confident that his extensive leadership experience will be of great value as we partner with him to invest in this space.”

“I have long admired the way Frazier’s Growth Buyout team approaches sourcing and growing promising healthcare companies, and I am thrilled to be joining this great team,” said Mr. Chandler. “I am excited to work alongside Frazier to identify and work with disruptive growth-oriented healthcare companies.”

Mr. Chandler was most recently the President of Global Pharma Services at Cencora (NYSE: COR; f.k.a. Amerisource Bergen), where he led the multi-billion dollar business unit with 10,000 employees. Prior to his role leading the global pharma services segment, Mr. Chandler was Cencora’s President of Health System, Specialty, Government, and Commercial Solutions where he led all distribution and services into health systems and specialist facilities. Prior to Cencora, Mr. Chandler was the VP of Health System Alliances at CVS Health, and before that, he was the co-founder of Shields Specialty Pharmacy, a national leader in specialty pharmacy services for hospitals and health systems. Across his roles, Mr. Chandler has a demonstrated history of entrepreneurial leadership, commercial transformation, and acquisition integration.

About Frazier Healthcare Partners:

Founded in 1991, Frazier Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. Since its inception, Frazier has raised over $8 billion of capital for private funds and co-investment opportunities and has invested in more than 200 companies over 32 years. Frazier has a philosophy of partnering with strong management teams while leveraging its internal operating resources and network to build exceptional companies. Frazier is headquartered in Seattle, WA, and invests broadly across the U.S., Canada, and Europe.

For more information about Frazier Healthcare Partners, visit www.frazierhealthcare.com/home.

Contacts

Frazier Healthcare Partners
Carol Eckert, VP of Investor Relations
Phone: 206.621.7200
Email: carol.eckert@frazierhealthcare.com

Frazier Healthcare Partners


Release Versions

Contacts

Frazier Healthcare Partners
Carol Eckert, VP of Investor Relations
Phone: 206.621.7200
Email: carol.eckert@frazierhealthcare.com

More News From Frazier Healthcare Partners

Frazier Healthcare Partners Announces Strategic Minority Investment from Petershill at Goldman Sachs Alternatives

SEATTLE--(BUSINESS WIRE)--Frazier Healthcare Partners, a Seattle-based, healthcare-focused private capital firm, is pleased to announce a passive, minority investment from Petershill at Goldman Sachs Alternatives (“Petershill”). Terms of the transaction were not disclosed. Founded in 1991, Frazier Healthcare Partners (“Frazier”) has invested in more than 200 companies over 34 years. The firm recently closed its latest flagship fund, Frazier Healthcare Growth Buyout Fund XI, L.P. (“FHGB XI”), wh...

Frazier Healthcare Partners Announces Acquisition of DirectMed Imaging

SEATTLE--(BUSINESS WIRE)--Frazier Healthcare Partners (“Frazier”), a Seattle-based, healthcare-focused investment firm, announced today that it has completed the acquisition of DirectMed Imaging (“DirectMed” or the “Company”), a leading provider of aftermarket parts and component repairs for diagnostic imaging equipment, from NMS Capital. The partnership will leverage Frazier's growth-oriented investment experience and healthcare industry expertise to build upon DirectMed’s success as a leading...

Frazier Healthcare Partners Announces the Promotion of Clarissa Berman to Principal

SEATTLE--(BUSINESS WIRE)--Frazier Healthcare Partners today announced the promotion of Clarissa Berman to Principal on the Growth Buyout Investment Professional (IP) team. Clarissa joined Frazier in 2019 and has been an integral part of the firm. She has been instrumental in several deals, including RevSpring, AirLife, EPTAM Precision, and Effective School Solutions. Clarissa was also part of the team leading the firm’s investment in Elevate Patient Financial Solutions. Prior to Frazier, she wo...
Back to Newsroom